J.E.M. Groener

7.2k citations

96 papers · 5.7k indexed · 2 hit papers · h-index 42

Impact in

Physiology top 0.2%
- Lysosomal Storage Disorders Research
Cell Biology top 0.5%
- Cellular transport and secretion

Papers in

Physiology 58
- Lysosomal Storage Disorders Research 46
Biochemistry 13
- Lipid metabolism and biosynthesis 13

Co-authors: Johannes M. F. G. Aerts Carla E. M. Hollak Ben J. H. M. Poorthuis Rolf G. Boot Gabor E. Linthorst Ron A. Wevers O. P. van Diggelen Frits A. Wijburg
Journals: Journal of Inherited Metabolic Disease (10 papers)Molecular Genetics and Metabolism (7 papers)The Journal of Clinical Endocrinology & Metabolism (6 papers)Atherosclerosis (5 papers)Advances in experimental medicine and biology (4 papers)
Partner nations: Netherlands United States Finland

In The Last Decade

J.E.M. Groener

96 papers receiving 5.6k citations

Hit Papers

align trajectories log scale

Elevated globotriaosylsphingosine is a hallmark of Fabry disease 2008 · 566 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Proceedings of the National Academy of Sciences
1999 Human Genetics

Peers

Countries citing papers authored by J.E.M. Groener

Since Specialization

Citations

This map shows the geographic impact of J.E.M. Groener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.E.M. Groener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.E.M. Groener more than expected).

Fields of papers citing papers by J.E.M. Groener

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.E.M. Groener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.E.M. Groener. The network helps show where J.E.M. Groener may publish in the future.

Co-authors

The 25 scholars most cited alongside J.E.M. Groener, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J.E.M. Groener Line = papers co-authored together J.E.M. Groener links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes Haematologica ·Laura van Dussen, Timothy M. Cox, Erik Hendriks, Edward P. Morris, Erik M. Akkerman, Mario Maas, J.E.M. Groener, Johannes M. F. G. Aerts, Patrick Deegan, Carla E. M. Hollak	2012	15
2	Glycosphingolipids and Insulin Resistance Advances in experimental medicine and biology ·Johannes M. F. G. Aerts, Rolf G. Boot, Marco van Eijk, J.E.M. Groener, Nora Bijl, Elisa Lombardo, Florence Biétrix, Nick Dekker, Albert K. Groen, Roelof Ottenhoff, Cindy van Roomen, Jan Aten, Mireille J. Serlie, Mirjam Langeveld, Tom Wennekes, Herman S. Overkleeft	2011	52
3	Gaucher disease due to saposin C deficiency, previously described as non-neuronopathic form — No positive effects after 2-years of miglustat therapy Molecular Genetics and Metabolism ·Anna Tylki‐Szymańska, J.E.M. Groener, Marek Leszek Kamiński, Agnieszka Ługowska, Elżbieta Jurkiewicz, Barbara Czartoryska	2011	19
4	Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients Orphanet Journal of Rare Diseases ·Bouwien E. Smid, Saskia M. Rombach, Johannes M. F. G. Aerts, S.H. Kuiper, Mina Mirzaian, Herman S. Overkleeft, Ben J. H. M. Poorthuis, Carla E. M. Hollak, J.E.M. Groener, Gabor E. Linthorst	2011	53
5	Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry disease Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Saskia M. Rombach, Natashe Lemos Dekker, Machtelt G. Bouwman, Gabor E. Linthorst, A. H. Zwinderman, Frits A. Wijburg, Sara Z. Kuiper, M. A. vd Bergh Weerman, J.E.M. Groener, Ben J. H. M. Poorthuis, Carla E. M. Hollak, Johannes M. F. G. Aerts	2010	189
6	Kupffer Cells Promote Hepatic Steatosis Via Interleukin-1β–Dependent Suppression of Peroxisome Proliferator-Activated Receptor α Activity Hepatology ·Rinke Stienstra, Fredy Z. Saudale, Caroline Duval, Shohreh Keshtkar, J.E.M. Groener, Nico van Rooijen, Bart Staels, Sander Kersten, Michael Müller	2009	368
7	Deficiency in N-acetylgalactosamine-6-sulfate sulfatase results in collagen perturbations in cartilage of Morquio syndrome A patients Molecular Genetics and Metabolism ·Ruud A. Bank, J.E.M. Groener, J. J. van Gemund, Petra D. Maaswinkel, Kees A. Hoeben, Herman A.J. Schut, Vincent Everts	2009	27
8	Detection of chitinase activity by 2-aminobenzoic acid labeling of chito-oligosaccharides Analytical Biochemistry ·Karen Ghauharali‐van der Vlugt, Anton P. Bussink, J.E.M. Groener, Rolf G. Boot, Johannes M. F. G. Aerts	2008	8
9	Low frequency maintenance therapy with imiglucerase in adult type I Gaucher disease: a prospective randomized controlled trial Haematologica ·Maaike de Fost, Johannes M. F. G. Aerts, J.E.M. Groener, Mario Maas, Erik M. Akkerman, Maaike G. Wiersma, Carla E. M. Hollak	2007	24
10	Monitoring of Gaucher patients with a novel chitotriosidase assay Clinica Chimica Acta ·A. Onrust-van Schoonhoven, Bernard Rudensky, Debbie Elstein, Ari Zimran, Carla E. M. Hollak, J.E.M. Groener, Johannes M. F. G. Aerts	2007	67
11	Clinical variability in mucolipidosis III (pseudo‐Hurler polydystrophy) American Journal of Medical Genetics ·Anna Tylki‐Szymańska, Barbara Czartoryska, J.E.M. Groener, Agnieszka Ługowska	2002	19
12	Biosynthesis of Phosphatidylcholine from a Phosphocholine Precursor Pool Derived from the Late Endosomal/Lysosomal Degradation of Sphingomyelin Journal of Biological Chemistry ·Suzanne M. Jansen, J.E.M. Groener, Wim Bax, Anke Suter, Paul Säftig, Pentti Somerharju, Ben J. H. M. Poorthuis	2001	14
13	Difference in substrate specificity between human and mouse lysosomal acid lipase: low affinity for cholesteryl ester in mouse lysosomal acid lipase Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·J.E.M. Groener, Wim Bax, Cristiana Stuani, (unknown)	2000	5
14	The frequency of lysosomal storage diseases in The Netherlands Human Genetics ·Ben J. H. M. Poorthuis, Ron A. Wevers, Wim J. Kleijer, J.E.M. Groener, J.G.N. de Jong, Sonja van Weely, Klary E. Niezen‐Koning, O. P. van Diggelen Hit paper breakdown →	1999	522
15	Lowering of Serum Cholesteryl Ester Transfer Protein—But Not Lecithin:Cholesterol Acyltransferase—Activity Levels by Hypocholesterolemic Drugs in the Rabbit Cardiovascular Drugs and Therapy ·Gert W. Meijer, J.E.M. Groener, A.C. Beynen, Arie van Tol	1998	8
16	Induction of net mass lipid transfer reactions in plasma by wine consumption with dinner European Journal of Clinical Investigation ·Arie van Tol, J.E.M. Groener, L.M. Scheek, Teus van Gent, Jan A. Veenstra, H. van de Pol, H. Hendriks, G. Schaafsma	1995	36
17	Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma Atherosclerosis ·Han Speijer, J.E.M. Groener, E VANRAMSHORST, A VANTOL	1991	133
18	Lipoprotein Structure and Metabolism During Progression and Regression of Atherosclerosis in Pigs Fed With Fish Oil-Derived Fatty Acids Advances in experimental medicine and biology ·Arie van Tol, Teus van Gent, L.M. Scheek, J.E.M. Groener, L.M.A. Sassen, Jos M. J. Lamers, Pieter D. Verdouw	1990	4
19	Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·J.E.M. Groener, Teus van Gent, Arie van Tol	1989	41
20	Cholesterol Esterification and Net Mass Transfer of Cholesterylesters and Triglycerides in Plasma From Healthy Subjects and Hyperlipidemic Coronary Heart Disease Patients Advances in experimental medicine and biology ·Arie van Tol, L.M. Scheek, J.E.M. Groener	1988	5

About J.E.M. Groener

J.E.M. Groener is a scholar working on Physiology, Biochemistry, Endocrinology, Diabetes and Metabolism, Epidemiology and Cell Biology, having authored 96 papers that have together received 5.7k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (46 papers), Trypanosoma species research and implications (19 papers), Studies on Chitinases and Chitosanases (18 papers), Carbohydrate Chemistry and Synthesis (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Lipid metabolism and biosynthesis (13 papers), Cholesterol and Lipid Metabolism (12 papers) and Peroxisome Proliferator-Activated Receptors (12 papers). The work is most often cited by research in Physiology (3.7k citations), Cell Biology (1.3k citations), Epidemiology (2.0k citations), Endocrinology, Diabetes and Metabolism (789 citations) and Biochemistry (275 citations). J.E.M. Groener has collaborated with scholars based in Netherlands, United States and Finland. Frequent co-authors include Johannes M. F. G. Aerts, Carla E. M. Hollak, Ben J. H. M. Poorthuis, Rolf G. Boot, Gabor E. Linthorst, Ron A. Wevers, O. P. van Diggelen, Frits A. Wijburg, D.W. Erkelens and Gerhard M. Kostner. Their work appears in journals such as Journal of Inherited Metabolic Disease, Molecular Genetics and Metabolism, The Journal of Clinical Endocrinology & Metabolism, Atherosclerosis and Advances in experimental medicine and biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact